Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
Background: This prospective, multicentre, observational INVIDIa-2 study is investigating the clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune-checkpoint inhibitors (ICIs), enrolled in 82 Italian centres, from October 2019 to January 2020. The primary endpoint...
Similar Items
-
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
by: Shobana Anpalakhan, et al.
Published: (2023-11-01) -
Insufficienza renale acuta del postpartum: una diagnosi complessa?
by: Giuseppe Gernone, et al.
Published: (2013-11-01) -
Characterization of a decellularized pericardium extracellular matrix hydrogel for regenerative medicine: insights on animal-to-animal variability
by: Dalila Di Francesco, et al.
Published: (2024-08-01) -
Soil Footprint and Land-Use Change to Clean Energy Production: Implications for Solar and Wind Power Plants
by: Alessia Cogato, et al.
Published: (2023-09-01) -
Biological Materials for Tissue-Engineered Vascular Grafts: Overview of Recent Advancements
by: Dalila Di Francesco, et al.
Published: (2023-09-01)